Evaluating the ready biodegradability of two poorly water-soluble substances: comparative approach of bioavailability improvement methods (BIMs)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1614-7499
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Evaluating the ready biodegradability of two poorly water-soluble substances: comparative approach of bioavailability improvement methods (BIMs) ; day:28 ; month:5 ; year:2016 ; pages:1-11
Environmental science and pollution research ; (28.5.2016), 1-11
- Urheber
-
Sweetlove, Cyril
- Beteiligte Personen und Organisationen
-
Chenèble, Jean-Charles
Barthel, Yves
Boualam, Marc
L’Haridon, Jacques
Thouand, Gérald
SpringerLink (Online service)
- DOI
-
10.1007/s11356-016-6899-3
- URN
-
urn:nbn:de:1111-20160530530
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sweetlove, Cyril
- Chenèble, Jean-Charles
- Barthel, Yves
- Boualam, Marc
- L’Haridon, Jacques
- Thouand, Gérald
- SpringerLink (Online service)
Ähnliche Objekte (12)
Novel formulation principles for bioavailability enhancement of poorly water-soluble and poorly permeable drugs
Solubility/Bioavailability Enhancement and Modified Release Formulations of Poorly Water-Soluble Drugs
Relevance of bioaccessibility for the oral bioavailability of poorly water-soluble drugs
Improved oral bioavailability of poorly water-soluble vorinostat by self-microemulsifying drug delivery system
LIPOSOMES AS A LIPID-BASED FORMULATION TO INCREASE THE BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUG FENOFIBRATE
Nucleation Precursors of Poorly Water-Soluble Pharmaceutical Compounds
Development of Proliposomal and Liposomal Formulations with Poorly Water-soluble Drugs
Leveraging bile solubilization of poorly water-soluble drugs by rational polymer selection
Nanostructured lipid carrier formulation for delivering poorly water-soluble ITF3756 HDAC inhibitor
Non‐Aqueous Phospholipid Concentrates for Increasing the Bioavailability of Poorly Soluble Compounds
Water-Soluble Metalated Covalent Organic Nanobelts with Improved Bioavailability for Protein Transportation
Springs and parachutes - development and characterization of novel formulations for poorly water-soluble drugs
Novel formulation principles for bioavailability enhancement of poorly water-soluble and poorly permeable drugs
Solubility/Bioavailability Enhancement and Modified Release Formulations of Poorly Water-Soluble Drugs
Relevance of bioaccessibility for the oral bioavailability of poorly water-soluble drugs
Improved oral bioavailability of poorly water-soluble vorinostat by self-microemulsifying drug delivery system
LIPOSOMES AS A LIPID-BASED FORMULATION TO INCREASE THE BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUG FENOFIBRATE
Nucleation Precursors of Poorly Water-Soluble Pharmaceutical Compounds
Development of Proliposomal and Liposomal Formulations with Poorly Water-soluble Drugs
Leveraging bile solubilization of poorly water-soluble drugs by rational polymer selection
Nanostructured lipid carrier formulation for delivering poorly water-soluble ITF3756 HDAC inhibitor
Non‐Aqueous Phospholipid Concentrates for Increasing the Bioavailability of Poorly Soluble Compounds
Water-Soluble Metalated Covalent Organic Nanobelts with Improved Bioavailability for Protein Transportation
Springs and parachutes - development and characterization of novel formulations for poorly water-soluble drugs
Novel formulation principles for bioavailability enhancement of poorly water-soluble and poorly permeable drugs
Solubility/Bioavailability Enhancement and Modified Release Formulations of Poorly Water-Soluble Drugs
Relevance of bioaccessibility for the oral bioavailability of poorly water-soluble drugs
Improved oral bioavailability of poorly water-soluble vorinostat by self-microemulsifying drug delivery system
LIPOSOMES AS A LIPID-BASED FORMULATION TO INCREASE THE BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUG FENOFIBRATE
Nucleation Precursors of Poorly Water-Soluble Pharmaceutical Compounds
Development of Proliposomal and Liposomal Formulations with Poorly Water-soluble Drugs
Leveraging bile solubilization of poorly water-soluble drugs by rational polymer selection
Nanostructured lipid carrier formulation for delivering poorly water-soluble ITF3756 HDAC inhibitor
Non‐Aqueous Phospholipid Concentrates for Increasing the Bioavailability of Poorly Soluble Compounds
Water-Soluble Metalated Covalent Organic Nanobelts with Improved Bioavailability for Protein Transportation